Dr Nathan Lack

Dr. Nathan Lack is a Senior Research Scientist at the Vancouver Prostate Centre. He obtained a DPhil (PhD) in Pharmacology from the University of Oxford in 2009 and then did a Postdoctoral Fellowship at the Vancouver Prostate Centre with Dr. Emma Guns and Professor Paul Rennie. Nathan became an Assistant Professor at Koç University in the School of Medicine (Istanbul) in 2011 and was awarded Associate Professorship in 2015. In addition to his academic research, Nathan previously worked for AnorMED Inc., where he was involved in the development of the FDA-approved therapeutic Plerixafor.

The Lack Laboratory is focused on identify and characterizing novel drug targets to treat aggressive late-stage prostate cancer by utilizing advanced functional genomics techniques in combination with classical pharmacology. In addition to extensive publications, the research from his group has identified several compounds that have been licenced and progressed to clinical development. Since it’s initiation, the Lack laboratory has obtained several million dollars of funding from national, international and industrial sources. For this work, Nathan has received numerous awards including the Vancouver Coast Health Research Institute’s Rising Star and the prestigious TÜBA-GEBIP which is given to the best young scientists in Turkey.

For further information, please see his laboratory website.